In the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled Latitude PsO 3001 and 3002 studies, more than half of patients treated with zasocitinib achieved clear ...
Is Nvidia's forthcoming DLSS 5, shown GTC 2026, a game-ethics question mark? Is it spectacular? Yes and yes. Here are my first impressions from a demo Nvidia showed me. A Chinese national and two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results